Medical Device User Fee Rates for Fiscal Year 2016, 46033-46039 [2015-18907]

Download as PDF 46033 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http:// www.regulations.gov. IV. Electronic Access Persons with access to the Internet may obtain the guidance at either http:// www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatory Information/Guidances/default.htm or http://www.regulations.gov. Dated: July 29, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–18956 Filed 7–31–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–0007] Medical Device User Fee Rates for Fiscal Year 2016 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the fee rates and payment procedures for medical device user fees for fiscal year (FY) 2016. The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Medical Device User Fee Amendments of 2012 (MDUFA III), authorizes FDA to collect user fees for certain medical device submissions and annual fees both for certain periodic reports and for establishments subject to registration. This notice establishes the fee rates for FY 2016, which apply from October 1, 2015, through September 30, 2016. To avoid delay in the review of your application, you should pay the application fee before or at the time you submit your application to FDA. The fee you must pay is the fee that is in effect on the later of the date that your application is received by FDA or the date your fee payment is recognized by the U.S. Treasury. If you want to pay a reduced small business fee, you must qualify as a small business before making your submission to FDA; if you do not qualify as a small business before mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: making your submission to FDA, you will have to pay the higher standard fee. Please note that the establishment registration fee is not eligible for a reduced small business fee. As a result, if the establishment registration fee is the only medical device user fee that you will pay in FY 2016, you should not submit a FY 2016 Small Business Qualification and Certification request. This document provides information on how the fees for FY 2016 were determined, the payment procedures you should follow, and how you may qualify for reduced small business fees. FOR FURTHER INFORMATION CONTACT: For information on Medical Device User Fees: Visit FDA’s Web site at http:// www.fda.gov/mdufa. For questions relating to this notice: David Miller, Office of Financial Management, Food and Drug Administration, 8455 Colesville Rd. (COLE–14202E), Silver Spring, MD 20993–0002, 301–796–7103. SUPPLEMENTARY INFORMATION: I. Background Section 738 of the FD&C Act (21 U.S.C. 379j) establishes fees for certain medical device applications, submissions, supplements, and notices (for simplicity, this document refers to these collectively as ‘‘submissions’’ or ‘‘applications’’); for periodic reporting on class III devices; and for the registration of certain establishments. Under statutorily defined conditions, a qualified applicant may receive a fee waiver or may pay a lower small business fee. (See 21 U.S.C. 379j(d) and (e).) Additionally, the Secretary of Health and Human Services (the Secretary) may, at the Secretary’s sole discretion, grant a fee waiver or reduction if the Secretary finds that such waiver or reduction is in the interest of public health. (See 21 U.S.C. 379j(f).) Under the FD&C Act, the fee rate for each type of submission is set at a specified percentage of the standard fee for a premarket application (a premarket application is a premarket approval application (PMA), a product development protocol (PDP), or a biologics license application (BLA)). The FD&C Act specifies the base fee for a premarket application for each year from FY 2013 through FY 2017; the base fee for a premarket application received by FDA during FY 2016 is $263,180. From this starting point, this document establishes FY 2016 fee rates for other types of submissions, and for periodic reporting, by applying criteria specified in the FD&C Act. The FD&C Act specifies the base fee for establishment registration for each year from FY 2013 through FY 2017; the base fee for an establishment registration in FY 2016 is $3,872. There is no reduction in the registration fee for small businesses. Each establishment that is registered (or is required to register) with the Secretary under section 510 of the FD&C Act (21 U.S.C. 360) because such establishment is engaged in the manufacture, preparation, propagation, compounding, or processing of a device is required to pay the annual fee for establishment registration. II. Revenue Amount for FY 2016 The total revenue amount for FY 2016 is $129,339,949, as set forth in the statute prior to the inflation adjustment. (See 21 U.S.C. 379j(b)(3)(D)). MDUFA III (Pub. L. 112–144) directs FDA to use the yearly total revenue amount as a starting point to set the standard fee rates for each fee type. The fee calculations for FY 2016 are described in this document. Inflation Adjustment MDUFA III specifies that the $129,339,949 is to be adjusted for inflation increases for FY 2016 using two separate adjustments—one for payroll costs and one for non-pay costs (see 21 U.S.C. 379j(c)(2)). The base inflation adjustment for FY 2016 is the sum of one plus these two separate adjustments, and is compounded as specified (see 21 U.S.C. 379j(c)(2)(C)(1) and 379j(c)(2)(B)(ii)). The component of the inflation adjustment for payroll costs is the average annual percent change in the cost of all personnel compensation and benefits (PC&B) paid per full-time equivalent position (FTE) at FDA for the first 3 of the 4 preceding FYs, multiplied by 0.60, or 60 percent (see 21 U.S.C. 379j(c)(2)(C)). Table 1 summarizes the actual cost and FTE data for the specified FYs, and provides the percent change from the previous FY and the average percent change over the first 3 of the 4 FYs preceding FY 2016. The 3-year average is 2.2328 percent (rounded). TABLE 1—FDA PC&BS EACH YEAR AND PERCENT CHANGE Fiscal year 2012 Total PC&B .............................................................................. Total FTE ................................................................................. VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 PO 00000 Frm 00102 $1,824,703,000 13,382 Fmt 4703 Sfmt 4703 2013 $1,927,703,000 13,974 E:\FR\FM\03AUN1.SGM 2014 $2,054,937,000 14,555 03AUN1 3-Year average 46034 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices TABLE 1—FDA PC&BS EACH YEAR AND PERCENT CHANGE—Continued Fiscal year 2012 PC&B per FTE ......................................................................... Percent change from previous year ........................................ The payroll adjustment is 2.2328 percent multiplied by 60 percent, or 1.3397 percent. The statute specifies that the component of the inflation adjustment for non-payroll costs for FY 2016 is the average annual percent change that occurred in the Consumer Price Index (CPI) for urban consumers (Washington- 2013 $136,355 3.1843% 2014 $137,949 1.1690% 3-Year average $141,184 2.3451% 2.2328% Washington area. These data are published by the Bureau of Labor Statistics and can be found on their Web site at http://data.bls.gov/cgi-bin/ surveymost?cu by checking the box marked ‘‘Washington-Baltimore All Items, November 1996=100— CUURA311SA0’’ and then clicking on the ‘‘Retrieve Data’’ button. Baltimore, DC–MD–VA–WV; not seasonally adjusted; all items; annual index) for the first 3 of the preceding 4 years of available data multiplied by 0.40, or 40 percent (see 21 U.S.C. 379j(c)(2)(C)). Table 2 provides the summary data and the 3-year average percent change in the specified CPI for the Baltimore- TABLE 2—ANNUAL AND 3-YEAR AVERAGE PERCENT CHANGE IN BALTIMORE-WASHINGTON AREA CPI Fiscal year 2012 2013 2014 Annual CPI ............................................................................... Annual Percent Change .......................................................... 3-Yr Avg. Percent Change in CPI ........................................... 150.212 2.2024% .............................. 152.500 1.5232% .............................. 154.847 1.5390% .............................. The non-pay adjustment is 1.7549 percent multiplied by 40 percent, or 0.7019 percent. Next, the payroll adjustment (1.3397 percent or 0.013397) is added to the non-pay adjustment (0.7019 percent or 0.007019), for a total of 2.0416 percent (or 0.020416). To complete the inflation adjustment, 1 (100 percent or 1.0) is added for a total base inflation adjustment of 1.020416 for FY 2016. MDUFA III provides for this inflation adjustment to be compounded for FY 2015 and each subsequent fiscal year (see 21 U.S.C. 379j(c)(2)(B)(ii)). The base 3-Year average 1.7549% III. Fees for FY 2016 inflation adjustment for FY 2016 (1.020416) is compounded by multiplying it by the compounded applicable inflation adjustment for FY 2015 (1.04316), as published in the Federal Register of July 30, 2014 (79 FR 44178 to 44184), to reach the applicable inflation adjustment of 1.064457 (rounded) (1.020416 times 1.04316) for FY 2016. We then multiply the total revenue amount for FY 2016 ($129,339,949) by 1.064457, yielding an inflation adjusted total revenue amount of $137,677,000 (rounded to the nearest thousand dollars). Under the FD&C Act, all submission fees and the periodic reporting fee are set as a percent of the standard (full) fee for a premarket application (see 21 U.S.C. 379j(a)(2)(A)). Table 3 provides the last 3 years of fee paying submission counts and the 3-year average. These numbers are used to project the fee paying submission counts that FDA will receive in FY 2016. The fee paying submission counts are published in the MDUFA Financial Report to Congress each year. TABLE 3—3-YEAR AVERAGE OF FEE PAYING SUBMISSIONS mstockstill on DSK4VPTVN1PROD with NOTICES Application type FY 2012 actual Full Fee Applications ............................................................... Small Business ................................................................. Panel-Track Supplement ......................................................... Small Business ................................................................. 180-Day Supplements ............................................................. Small Business ................................................................. Real-Time Supplements .......................................................... Small Business ................................................................. 510(k)s ..................................................................................... Small Business ................................................................. 30-Day Notice .......................................................................... Small Business ................................................................. 513(g) Request for Classification Information ......................... Small Business ................................................................. Annual Fee for Periodic Reporting 1 ........................................ Small Business 1 ............................................................... Establishment Registration 2 .................................................... 25 6 12 0 145 21 196 22 2,865 1,086 801 60 46 30 478 39 .............................. 1 Includes FY 2013 actual FY 2014 actual 23 9 19 0 128 21 182 23 3,149 1,202 956 69 65 38 614 54 23,477 25 5 12 3 122 24 192 19 3,034 1,037 934 91 69 31 514 56 24,026 3-Year average 24 7 14 1 132 22 190 21 3,016 1,108 897 73 60 33 535 50 23,752 collection of quarter 4 billing for FY 2014 during FY 2015. Registration total comes from the registration system and will vary from the financial report. 2 Establishment The information in Table 3 is necessary to estimate the amount of VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 revenue that will be collected based on the fee amounts. Table 4 displays both PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 the estimated revenue using the FY 2016 base fees set in statute and the E:\FR\FM\03AUN1.SGM 03AUN1 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices estimated revenue after the inflation adjustment to the FY 2016 base fees. Using the fees set in statute and the 3year averages of fee paying submissions, the collections would total $138,620,884, which is $943,884 higher than the statutory revenue limit. Accordingly the PMA and establishment fee need to be decreased so that collections come as close to the statutory revenue limit of $137,677,000 as possible without exceeding the limit. This is done by calculating the percentage difference between the statutory revenue limit and the estimated resulting 2016 revenue collections, and then lowering the fees proportionally by that percentage 46035 (rounded to the nearest dollar). After recalculating the fees, a further $1 negative adjustment is made to the establishment fee in order for the estimated revenue to not exceed the statutory limit. The fees in the second column from the right are those we are establishing in FY 2016, which are the standard fees. TABLE 4—FEES NEEDED TO ACHIEVE NEW FY 2016 REVENUE TARGET FY 2016 Statutory fees (base fees) Application type Estimated resulting 2016 revenue Adjusted FY 2016 fees to meet revenue target (standard fees) FY 2016 revenue from adjusted fees Full Fee Applications ............................................................... Small Business ................................................................. Panel-Track Supplement ......................................................... Small Business ................................................................. 180-Day Supplements ............................................................. Small Business ................................................................. Real-Time Supplements .......................................................... Small Business ................................................................. 510(k)s ..................................................................................... Small Business ................................................................. 30-Day Notice .......................................................................... Small Business ................................................................. 513(g) Request for Classification Information ......................... Small Business ................................................................. Annual Fee for Periodic Reporting .......................................... Small Business ................................................................. Establishment Registration ...................................................... $263,180 65,795 197,385 49,346 39,477 9,869 18,423 4,606 5,264 2,632 $4,211 2,106 3,553 1,777 9,211 2,303 3,872 $6,316,320 460,565 2,763,390 49,346 5,210,964 217,118 3,500,370 96,726 15,876,224 2,916,256 $3,777,267 153,738 213,180 58,641 4,927,885 115,150 91,967,744 $261,388 65,347 196,041 49,010 39,208 9,802 18,297 4,574 5,228 2,614 $4,182 2,091 3,529 1,765 9,149 2,287 3,845 $6,273,312 457,429 2,744,574 49,010 5,175,456 215,644 3,476,340 96,054 15,764,648 2,896,312 $3,751,254 152,643 211,740 58,245 4,894,715 114,350 91,326,440 Total .................................................................................. .............................. 138,620,884 .............................. 137,661,256 The standard fee (adjusted base amount) for a premarket application, including a BLA, and for a premarket report and a BLA efficacy supplement, is $261,388 for FY 2016. The fees set by reference to the standard fee for a premarket application are: • For a panel-track supplement, 75 percent of the standard fee; • for a 180-day supplement, 15 percent of the standard fee; • for a real-time supplement, 7 percent of the standard fee; • for a 510(k) premarket notification, 2 percent of the standard fee; • for a 30-day notice, 1.6 percent of the standard fee; • for a 513(g) (21 U.S.C. 360c(g)) request for classification information, 1.35 percent of the standard fee; and • for an annual fee for periodic reporting concerning a class III device, 3.5 percent of the standard fee. For all submissions other than a 510(k) premarket notification, a 30-day notice, and a 513(g) request for classification information, the small business fee is 25 percent of the standard (full) fee for the submission. (See 21 U.S.C. 379j(d)(2)(C).) For a 510(k) premarket notification submission, a 30-day notice, and a 513(g) request for classification information, the small business fee is 50 percent of the standard (full) fee for the submission. (See 21 U.S.C. 379j(d)(2)(C) and (e)(2)(C).) The annual fee for establishment registration, after adjustment, is set at $3,845 for FY 2016. There is no small business rate for the annual establishment registration fee; all establishments pay the same fee. Table 5 summarizes the FY 2016 rates for all medical device fees. TABLE 5—MEDICAL DEVICE FEES FOR FY 2016 Standard fee (as a percent of the standard fee for a premarket application) mstockstill on DSK4VPTVN1PROD with NOTICES Application fee type Premarket application (a PMA submitted under section 515(c)(1) of the FD&C Act (21 U.S.C. 360e(c)(1)), a PDP submitted under section 515(f) of the FD&C Act (21 U.S.C. 360e(f)), or a BLA submitted under section 351 of the Public Health Service Act (the PHS Act) (42 U.S.C. 262)). Premarket report (submitted under section 515(c)(2) of the FD&C Act). Efficacy supplement (to an approved BLA under section 351 of the PHS Act). Panel-track supplement ..................................................................... 180-day supplement .......................................................................... Real-time supplement ........................................................................ 510(k) premarket notification submission .......................................... VerDate Sep<11>2014 19:53 Jul 31, 2015 Jkt 235001 PO 00000 Frm 00104 FY 2016 Standard fee FY 2016 Small business fee Base Fee Adjusted as Specified in the Statute. $261,388 $65,347 100 .............................................. 261,388 65,347 100 .............................................. 261,388 65,347 75 ................................................ 15 ................................................ 7 .................................................. 2 .................................................. 196,041 39,208 18,297 5,228 49,010 9,802 4,574 2,614 Fmt 4703 Sfmt 4703 E:\FR\FM\03AUN1.SGM 03AUN1 46036 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices TABLE 5—MEDICAL DEVICE FEES FOR FY 2016—Continued Standard fee (as a percent of the standard fee for a premarket application) Application fee type 30-day notice ..................................................................................... 513(g) request for classification information ..................................... Annual Fee Type: Annual fee for periodic reporting on a class III device .............. Annual establishment registration fee (to be paid by the establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device, as defined by 21 U.S.C. 379i(13)). IV. How To Qualify as a Small Business for Purposes of Medical Device Fees If your business has gross receipts or sales of no more than $100 million for the most recent tax year, you may qualify for reduced small business fees. If your business has gross sales or receipts of no more than $30 million, you may also qualify for a waiver of the fee for your first premarket application (PMA, PDP, or BLA) or premarket report. You must include the gross receipts or sales of all of your affiliates along with your own gross receipts or sales when determining whether you meet the $100 million or $30 million threshold. If you want to pay the small business fee rate for a submission, or you want to receive a waiver of the fee for your first premarket application or premarket report, you should submit the materials showing you qualify as a small business 60 days before you send your submission to FDA. If you make a submission before FDA finds that you qualify as a small business, you must pay the standard (full) fee for that submission. If your business qualified as a small business for FY 2015, your status as a small business will expire at the close of business on September 30, 2015. You must requalify for FY 2016 in order to pay small business fees during FY 2016. mstockstill on DSK4VPTVN1PROD with NOTICES A. Domestic (U.S.) Small Business If you are a domestic (U.S.) business, and wish to qualify as a small business for FY 2016, you must submit the following to FDA: 1. A completed FY 2016 MDUFA Small Business Qualification Certification (Form FDA 3602). This form is provided in FDA’s guidance document, ‘‘FY 2016 Medical Device User Fee Small Business Qualification and Certification,’’ available on FDA’s Web site at http://www.fda.gov/ MedicalDevices/ DeviceRegulationandGuidance/ GuidanceDocuments/default.htm. 2. A certified copy of your Federal (U.S.) Income Tax Return for the most VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 4,182 3,529 2,091 1,765 3.50 ............................................. Base Fee Adjusted as Specified in the Statute. 9,149 3,845 2,287 3,845 B. Foreign Small Business If you are a foreign business, and wish to qualify as a small business for FY 2016, you must submit the following: 1. A completed FY 2016 MDUFA Foreign Small Business Qualification Certification (Form FDA 3602A). This form is provided in FDA’s guidance document, ‘‘FY 2016 Medical Device Frm 00105 FY 2016 Small business fee 1.60 ............................................. 1.35 ............................................. recent tax year. The most recent tax year will be 2015, except: If you submit your FY 2016 MDUFA Small Business Qualification before April 15, 2016, and you have not yet filed your return for 2015, you may use tax year 2014. If you submit your FY 2016 MDUFA Small Business Qualification on or after April 15, 2016, and have not yet filed your 2015 return because you obtained an extension, you may submit your most recent return filed prior to the extension. 3. For each of your affiliates, either: • If the affiliate is a domestic (U.S.) business, a certified copy of the affiliate’s Federal (U.S.) Income Tax Return for the most recent tax year, or • if the affiliate is a foreign business and cannot submit a Federal (U.S.) Income Tax Return, a National Taxing Authority Certification completed by, and bearing the official seal of, the National Taxing Authority of the country in which the firm is headquartered. The National Taxing Authority is the foreign equivalent of the U.S. Internal Revenue Service. This certification must show the amount of gross receipts or sales for the most recent tax year, in both U.S. dollars and the local currency of the country, the exchange rate used in converting the local currency to U.S. dollars, and the dates of the gross receipts or sales collected. The applicant must also submit a statement signed by the head of the applicant’s firm or by its chief financial officer that the applicant has submitted certifications for all of its affiliates, identifying the name of each affiliate, or that the applicant has no affiliates. PO 00000 FY 2016 Standard fee Fmt 4703 Sfmt 4703 User Fee Small Business Qualification and Certification,’’ available on FDA’s Internet site at http://www.fda.gov/ MedicalDevices/ DeviceRegulationandGuidance/ GuidanceDocuments/default.htm. 2. A National Taxing Authority Certification, completed by, and bearing the official seal of, the National Taxing Authority of the country in which the firm is headquartered. This certification must show the amount of gross receipts or sales for the most recent tax year, in both U.S. dollars and the local currency of the country, the exchange rate used in converting the local currency to U.S. dollars, and the dates of the gross receipts or sales collected. 3. For each of your affiliates, either: • If the affiliate is a domestic (U.S.) business, a certified copy of the affiliate’s Federal (U.S.) Income Tax Return for the most recent tax year (2015 or later), or • if the affiliate is a foreign business and cannot submit a Federal (U.S.) Income Tax Return, a National Taxing Authority Certification completed by, and bearing the official seal of, the National Taxing Authority of the country in which the firm is headquartered. The National Taxing Authority is the foreign equivalent of the U.S. Internal Revenue Service. This certification must show the amount of gross receipts or sales for the most recent tax year, in both U.S. dollars and the local currency of the country, the exchange rate used in converting the local currency to U.S. dollars, and the dates for the gross receipts or sales collected. The applicant must also submit a statement signed by the head of the applicant’s firm or by its chief financial officer that the applicant has submitted certifications for all of its affiliates, identifying the name of each affiliate, or that the applicant has no affiliates. V. Procedures for Paying Application Fees If your application or submission is subject to a fee and your payment is E:\FR\FM\03AUN1.SGM 03AUN1 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices received by FDA between October 1, 2015, and September 30, 2016, you must pay the fee in effect for FY 2016. The later of the date that the application is received in the reviewing center’s document room or the date the U.S. Treasury recognizes the payment determines whether the fee rates for FY 2015 or FY 2016 apply. FDA must receive the correct fee at the time that an application is submitted, or the application will not be accepted for filing or review. FDA requests that you follow the steps below before submitting a medical device application subject to a fee to ensure that FDA links the fee with the correct application. (Note: In no case should the check for the fee be submitted to FDA with the application.) A. Secure a Payment Identification Number (PIN) and Medical Device User Fee Cover Sheet From FDA Before Submitting Either the Application or the Payment Log into the User Fee System at: https://userfees.fda.gov/OA_HTML/ mdufmaCAcdLogin.jsp. Complete the Medical Device User Fee cover sheet. Be sure you choose the correct application submission date range. (Two choices will be offered until October 1, 2015. One choice is for applications and fees that will be received on or before September 30, 2015, which are subject to FY 2015 fee rates. A second choice is for applications and fees received on or after October 1, 2015, which are subject to FY 2016 fee rates.) After completing data entry, print a copy of the Medical Device User Fee cover sheet and note the unique PIN located in the upper right-hand corner of the printed cover sheet. mstockstill on DSK4VPTVN1PROD with NOTICES B. Electronically Transmit a Copy of the Printed Cover Sheet With the PIN When you are satisfied that the data on the cover sheet are accurate, electronically transmit the data to FDA according to instructions on the screen. Applicants are required to set up a user account and password to assure data security in the creation and electronic submission of cover sheets. C. Submit Payment for the Completed Medical Device User Fee Cover Sheet 1. If paying with credit card or electronic check (Automated Clearing House (ACH) also known as eCheck): FDA has partnered with the U.S. Department of the Treasury to utilize Pay.gov, a Web-based payment system, for online electronic payment. You may make a payment via electronic check or credit card after submitting your cover sheet. To pay online, select the ‘‘Pay VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 Now’’ button. Credit card transactions for cover sheets cannot exceed $49,999.99. 2. If paying with a paper check: • All paper checks must be in U.S. currency from a U.S. bank and made payable to the Food and Drug Administration. (If needed, FDA’s tax identification number is 53–0196965.) • Please write your application’s unique PIN (from the upper right-hand corner of your completed Medical Device User Fee cover sheet) on your check. • Mail the paper check and a copy of the completed cover sheet to: Food and Drug Administration, P.O. Box 979033, St. Louis, MO 63197–9000. (Please note that this address is for payments of application and annual report fees only and is not to be used for payment of annual establishment registration fees.) If you prefer to send a check by a courier, the courier may deliver the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This address is for courier delivery only. Contact U.S. Bank at 314–418–4013 if you have any questions about courier delivery.) 3. If paying with a wire transfer: • Please include your application’s unique PIN (from the upper right-hand corner of your completed Medical Device User Fee cover sheet) in your wire transfer. Without the PIN, your payment may not be applied to your cover sheet and review of your application may be delayed. • The originating financial institution may charge a wire transfer fee. Ask your financial institution about the fee and add it to your payment to ensure that your cover sheet is fully paid. Use the following account information when sending a wire transfer: New York Federal Reserve Bank, U.S. Department of Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., Silver Spring, MD 20993–0002. FDA records the official application receipt date as the later of the following: (1) The date the application was received by FDA or (2) the date the U.S. Treasury recognizes the payment. It is helpful if the fee arrives at the bank at least 1 day before the application arrives at FDA. D. Submit Your Application to FDA With a Copy of the Completed Medical Device User Fee Cover Sheet Please submit your application and a copy of the completed Medical Device PO 00000 Frm 00106 Fmt 4703 Sfmt 4703 46037 User Fee cover sheet to one of the following addresses: 1. Medical device applications should be submitted to: Food and Drug Administration, Center for Devices and Radiological Health, Document Mail Center, 10903 New Hampshire Ave., Building 66, Rm. 0609, Silver Spring, MD 20993–0002. 2. Biologics license applications should be sent to: Food and Drug Administration, Center for Biologics Evaluation and Research, Document Control Center, 10903 New Hampshire Ave, Building 71, Rm. G112, Silver Spring, MD 20993–0002. VI. Procedures for Paying the Annual Fee for Periodic Reporting You will be invoiced at the end of the quarter in which your PMA Periodic Report is due. Invoices will be sent based on the details included on your PMA file. You are responsible for ensuring FDA has your current billing information, and you may update your contact information for the PMA by submitting an amendment. 1. The preferred payment method is online using electronic check (Automated Clearing House (ACH) also known as eCheck) or credit card (Discover, VISA, MasterCard, American Express). Secure electronic payments can be submitted using the User Fees Payment Portal at https:// userfees.fda.gov/pay. After searching for and locating your invoice, click ‘‘Pay Now’’ to be redirected to Pay.gov. Note that electronic payment options are based on the balance due. Payment by credit card is available for balances that do not exceed $49,999.99. If the balance exceeds this amount, only the ACH option is available. Payments must be drawn on U.S bank accounts or made with U.S. credit cards. 2. If paying with a paper check: All paper checks must be in U.S. currency from a U.S. bank and made payable to the Food and Drug Administration. (If needed, FDA’s tax identification number is 53–0196965.) • Please write your invoice number on the check. • Mail the paper check and a copy of invoice to: Food and Drug Administration, P.O. Box 979033, St. Louis, MO 63197–9000. (Please note that this address is for payments of application and annual report fees only and is not to be used for payment of annual establishment registration fees.) If you prefer to send a check by a courier, the courier may deliver the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005 Convention Plaza, St. Louis, MO 63101. E:\FR\FM\03AUN1.SGM 03AUN1 46038 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices (Note: This address is for courier delivery only. Contact the U.S. Bank at 314–418–4013 if you have any questions about courier delivery.) 3. If paying with a wire transfer: • Please include your invoice number in your wire transfer. Without the invoice number, your payment may not be applied and you may be referred to collections. • The originating financial institution may charge a wire transfer fee. Ask your financial institution about the fee and add it to your payment to ensure that your invoice is fully paid. Use the following account information when sending a wire transfer: New York Federal Reserve Bank, U.S. Department of the Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., Silver Spring, MD 20993–0002. mstockstill on DSK4VPTVN1PROD with NOTICES VII. Procedures for Paying Annual Establishment Fees To pay the annual establishment fee, firms must access the Device Facility User Fee (DFUF) Web site at https:// userfees.fda.gov/OA_HTML/furls.jsp. (FDA has verified the Web site address, but FDA is not responsible for any subsequent changes to the Web site address after this document publishes in the Federal Register.) Create a DFUF order and you will be issued a PIN when you place your order. After payment has been processed, you will be issued a payment confirmation number (PCN). You will not be able to register your establishment if you do not have a PIN and a PCN. An establishment required to pay an annual establishment registration fee is not legally registered in FY 2016 until it has completed the steps below to register and pay any applicable fee. (See 21 U.S.C. 379j(g)(2).) Companies that do not manufacture any product other than a licensed biologic are required to register in the Blood Establishment Registration (BER) system. FDA’s Center for Biologics Evaluation and Research (CBER) will send establishment registration fee invoices annually to these companies. A. Submit a DFUF Order With a PIN From FDA Before Registering or Submitting Payment To submit a DFUF Order, you must create or have previously created a user account and password for the user fee Web site listed previously in this section. After creating a user name and password, log into the Establishment Registration User Fee FY 2016 store. Complete the DFUF order by entering the number of establishments you are VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 registering that require payment. When you are satisfied that the information in the order is accurate, electronically transmit the data to FDA according to instructions on the screen. Print a copy of the final DFUF order and note the unique PIN located in the upper righthand corner of the printed order. B. Pay For Your DFUF Order Unless paying by credit card, all payments must be in U.S. currency and drawn on a U.S. bank. 1. If paying by credit card or electronic check (ACH or eCheck): The DFUF order will include payment information, including details on how you can pay online using a credit card or electronic check. Follow the instructions provided to make an electronic payment. 2. If paying with a paper check: You may pay by a check, in U.S. dollars and drawn on a U.S. bank, mailed to: Food and Drug Administration, P.O. Box 979108, St. Louis, MO 63197–9000. (Note: This address is different from the address for payments of application and annual report fees and is to be used only for payment of annual establishment registration fees.) If a check is sent by a courier that requests a street address, the courier can deliver the check to: U.S. Bank, Attn: Government Lockbox 979108, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This U.S. Bank address is for courier delivery only; do not send mail to this address.) Please make sure that both of the following are written on your check: (1) The FDA post office box number (P.O. Box 979108) and (2) the PIN that is printed on your order. Include a copy of your printed order when you mail your check. 3. If paying with a wire transfer: Wire transfers may also be used to pay annual establishment fees. To send a wire transfer, please read and comply with the following information: Include your order’s unique PIN (in the upper right-hand corner of your completed DFUF order) in your wire transfer. Without the PIN, your payment may not be applied to your facility and your registration may be delayed. The originating financial institution may charge a wire transfer fee. Ask your financial institution about the fee and add it to your payment to ensure that your order is fully paid. Use the following account information when sending a wire transfer: New York Federal Reserve Bank, U.S. Dept. of Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 021030004, PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., Silver Spring, MD 20993–0002. (If needed, FDA’s tax identification number is 53–0196965.) C. Complete the Information Online To Update Your Establishment’s Annual Registration for FY 2016, or To Register a New Establishment for FY 2016 Go to the Center for Devices and Radiological Health’s Web site at http:// www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ HowtoMarketYourDevice/ RegistrationandListing/default.htm and click the ‘‘Access Electronic Registration’’ link on the left side of the page. This opens up a new page with important information about the FDA Unified Registration and Listing System (FURLS). After reading this information, click on the ‘‘Access Electronic Registration’’ link in the middle of the page. This link takes you to an FDA Industry Systems page with tutorials that demonstrate how to create a new FURLS user account if your establishment did not create an account in FY 2015. Manufacturers of licensed biologics should register in the BER system at http://www.fda.gov/Biologics BloodVaccines/GuidanceCompliance RegulatoryInformation/Establishment Registration/BloodEstablishment Registration/default.htm. Enter your existing account ID and password to log into FURLS. From the FURLS/FDA Industry Systems menu, click on the Device Registration and Listing Module (DRLM) of FURLS button. New establishments will need to register and existing establishments will update their annual registration using choices on the DRLM menu. When you choose to register or update your annual registration, the system will prompt you through the entry of information about your establishment and your devices. If you have any problems with this process, email: reglist@cdrh.fda.gov or call 301–796–7400 for assistance. (Note: This email address and telephone number are for assistance with establishment registration only; they are not to be used for questions related to other aspects of medical device user fees.) Problems with BERS should be directed to http:// www.accessdata.fda.gov/scripts/email/ cber/bldregcontact.cfm or call 240–402– 8360. D. Enter Your DFUF Order PIN and PCN After completing your annual or initial registration and device listing, you will be prompted to enter your DFUF order PIN and PCN, when applicable. This process does not apply to establishments engaged only in the E:\FR\FM\03AUN1.SGM 03AUN1 Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices manufacture, preparation, propagation, compounding, or processing of licensed biologic devices. CBER will send invoices for payment of the establishment registration fee to such establishments. Dated: July 28, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–18907 Filed 7–31–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463, codified at 5 U.S.C. App.), notice is hereby given of the following meeting: Name: Advisory Committee on Heritable Disorders in Newborns and Children Dates and Times: August 27, 2015, 9 a.m. to 5 p.m. August 28, 2015, 10 a.m. to 1 p.m. Place: Webinar and In-Person, National Institutes of Health, 5635 Fishers Lane, Rockville, Maryland 20857 Status: The meeting will be open to the public with attendance limited to space availability. Participants also have the option of viewing the meeting via webinar. Whether attending in-person or via webinar, all participants must register for the meeting. Please register at https://www.blsmeetings.net/ ACHDNCAugust2015. The registration deadline is Friday, August 14, 2015, 11:59 p.m. Eastern Time. Purpose: The Advisory Committee on Heritable Disorders in Newborns and Children (Committee), as authorized by Public Health Service Act, Title XI, § 1111 (42 U.S.C. 300b-10), as amended by the Newborn Screening Saves Lives Reauthorization Act of 2014 (Pub. L. 113–240), was established to advise the Secretary of the Department of Health and Human Services about the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. In addition, the Committee’s recommendations regarding additional conditions/ heritable disorders for screening that have been adopted by the Secretary are VerDate Sep<11>2014 18:35 Jul 31, 2015 Jkt 235001 included in the Recommended Uniform Screening Panel (RUSP) and constitute part of the comprehensive guidelines supported by the Health Resources and Services Administration. Pursuant to section 2713 of the Public Health Service Act, codified at 42 U.S.C. 300gg–13, non-grandfathered health plans and group and individual health insurance issuers are required to cover evidence-informed care and screenings included in the HRSA-supported comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years (in the individual market, policy years) beginning on or after the date that is one year from the Secretary’s adoption of the condition for screening. Agenda: The meeting will include: (1) A final evidence review report on the Adrenoleukodystrophy (ALD) condition nomination for inclusion in the RUSP; (2) a presentation by the Newborn Screening Technical Assistance and Evaluation Program (NewSTEPs) on their activities and the NewSTEPs data repository, a centralized and secure database designed for state newborn screening programs to explore data to meet program needs; (3) updates on the implementation of screening for Severe Combined Immunodeficiency, Critical Congenital Heart Disease, and Pompe Disease; and (4) updates from workgroups focused on cost analysis in newborn screening, newborn screening timeliness, and pilot studies for evidence-based reviews of conditions. Following the final evidence review report on ALD, the Committee also is expected to vote on whether or not to recommend to the Secretary the addition of ALD to the RUSP. Agenda items are subject to change as necessary or appropriate. The agenda, webinar information, Committee Roster, Charter, presentations, and other meeting materials will be located on the Advisory Committee’s Web site at http://www.hrsa.gov/ advisorycommittees/mchbadvisory/ heritabledisorders. Public Comments: Members of the public may present oral comments and/ or submit written comments. Comments are part of the official Committee record. The public comment period is tentatively scheduled for both days of the meeting. Advance registration is required to present oral comments and/ or submit written comments. Please register at https://www.blsmeetings.net/ ACHDNCAugust2015. The registration deadline is Friday, August 14, 2015, 11:59 p.m. Eastern Time. Written comments must be received by the deadline in order to be included in the August meeting briefing book. Written PO 00000 Frm 00108 Fmt 4703 Sfmt 4703 46039 comments should identify the individual’s name, address, email, telephone number, professional or business affiliation, type of expertise (i.e., parent, researcher, clinician, public health, etc.), and the topic/subject matter of comments. To ensure that all individuals who have registered to make oral comments can be accommodated, the allocated time may be limited. Individuals who are associated with groups or have similar interests may be requested to combine their comments and present them through a single representative. No audiovisual presentations are permitted. For additional information or questions on public comments, please contact Lisa Vasquez, Maternal and Child Health Bureau, Health Resources and Services Administration; email: lvasquez@ hrsa.gov. Contact Person: Anyone interested in obtaining other relevant information should contact Debi Sarkar, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18W68, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857; email: dsarkar@hrsa.gov.More information on the Advisory Committee is available at http://www.hrsa.gov/ advisorycommittees/mchbadvisory/ heritabledisorders. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015–18953 Filed 7–31–15; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: HIV Molecular Biology. Date: August 7, 2015. E:\FR\FM\03AUN1.SGM 03AUN1

Agencies

[Federal Register Volume 80, Number 148 (Monday, August 3, 2015)]
[Notices]
[Pages 46033-46039]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18907]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0007]


Medical Device User Fee Rates for Fiscal Year 2016

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the fee 
rates and payment procedures for medical device user fees for fiscal 
year (FY) 2016. The Federal Food, Drug, and Cosmetic Act (the FD&C 
Act), as amended by the Medical Device User Fee Amendments of 2012 
(MDUFA III), authorizes FDA to collect user fees for certain medical 
device submissions and annual fees both for certain periodic reports 
and for establishments subject to registration. This notice establishes 
the fee rates for FY 2016, which apply from October 1, 2015, through 
September 30, 2016. To avoid delay in the review of your application, 
you should pay the application fee before or at the time you submit 
your application to FDA. The fee you must pay is the fee that is in 
effect on the later of the date that your application is received by 
FDA or the date your fee payment is recognized by the U.S. Treasury. If 
you want to pay a reduced small business fee, you must qualify as a 
small business before making your submission to FDA; if you do not 
qualify as a small business before making your submission to FDA, you 
will have to pay the higher standard fee. Please note that the 
establishment registration fee is not eligible for a reduced small 
business fee. As a result, if the establishment registration fee is the 
only medical device user fee that you will pay in FY 2016, you should 
not submit a FY 2016 Small Business Qualification and Certification 
request. This document provides information on how the fees for FY 2016 
were determined, the payment procedures you should follow, and how you 
may qualify for reduced small business fees.

FOR FURTHER INFORMATION CONTACT: For information on Medical Device User 
Fees: Visit FDA's Web site at http://www.fda.gov/mdufa.
    For questions relating to this notice: David Miller, Office of 
Financial Management, Food and Drug Administration, 8455 Colesville Rd. 
(COLE-14202E), Silver Spring, MD 20993-0002, 301-796-7103.

SUPPLEMENTARY INFORMATION:

I. Background

    Section 738 of the FD&C Act (21 U.S.C. 379j) establishes fees for 
certain medical device applications, submissions, supplements, and 
notices (for simplicity, this document refers to these collectively as 
``submissions'' or ``applications''); for periodic reporting on class 
III devices; and for the registration of certain establishments. Under 
statutorily defined conditions, a qualified applicant may receive a fee 
waiver or may pay a lower small business fee. (See 21 U.S.C. 379j(d) 
and (e).) Additionally, the Secretary of Health and Human Services (the 
Secretary) may, at the Secretary's sole discretion, grant a fee waiver 
or reduction if the Secretary finds that such waiver or reduction is in 
the interest of public health. (See 21 U.S.C. 379j(f).)
    Under the FD&C Act, the fee rate for each type of submission is set 
at a specified percentage of the standard fee for a premarket 
application (a premarket application is a premarket approval 
application (PMA), a product development protocol (PDP), or a biologics 
license application (BLA)). The FD&C Act specifies the base fee for a 
premarket application for each year from FY 2013 through FY 2017; the 
base fee for a premarket application received by FDA during FY 2016 is 
$263,180. From this starting point, this document establishes FY 2016 
fee rates for other types of submissions, and for periodic reporting, 
by applying criteria specified in the FD&C Act.
    The FD&C Act specifies the base fee for establishment registration 
for each year from FY 2013 through FY 2017; the base fee for an 
establishment registration in FY 2016 is $3,872. There is no reduction 
in the registration fee for small businesses. Each establishment that 
is registered (or is required to register) with the Secretary under 
section 510 of the FD&C Act (21 U.S.C. 360) because such establishment 
is engaged in the manufacture, preparation, propagation, compounding, 
or processing of a device is required to pay the annual fee for 
establishment registration.

II. Revenue Amount for FY 2016

    The total revenue amount for FY 2016 is $129,339,949, as set forth 
in the statute prior to the inflation adjustment. (See 21 U.S.C. 
379j(b)(3)(D)). MDUFA III (Pub. L. 112-144) directs FDA to use the 
yearly total revenue amount as a starting point to set the standard fee 
rates for each fee type. The fee calculations for FY 2016 are described 
in this document.

Inflation Adjustment

    MDUFA III specifies that the $129,339,949 is to be adjusted for 
inflation increases for FY 2016 using two separate adjustments--one for 
payroll costs and one for non-pay costs (see 21 U.S.C. 379j(c)(2)). The 
base inflation adjustment for FY 2016 is the sum of one plus these two 
separate adjustments, and is compounded as specified (see 21 U.S.C. 
379j(c)(2)(C)(1) and 379j(c)(2)(B)(ii)).
    The component of the inflation adjustment for payroll costs is the 
average annual percent change in the cost of all personnel compensation 
and benefits (PC&B) paid per full-time equivalent position (FTE) at FDA 
for the first 3 of the 4 preceding FYs, multiplied by 0.60, or 60 
percent (see 21 U.S.C. 379j(c)(2)(C)).
    Table 1 summarizes the actual cost and FTE data for the specified 
FYs, and provides the percent change from the previous FY and the 
average percent change over the first 3 of the 4 FYs preceding FY 2016. 
The 3-year average is 2.2328 percent (rounded).

                                 Table 1--FDA PC&Bs Each Year and Percent Change
----------------------------------------------------------------------------------------------------------------
             Fiscal year                     2012               2013               2014          3-Year average
----------------------------------------------------------------------------------------------------------------
Total PC&B..........................     $1,824,703,000     $1,927,703,000     $2,054,937,000
Total FTE...........................             13,382             13,974             14,555

[[Page 46034]]

 
PC&B per FTE........................           $136,355           $137,949           $141,184
Percent change from previous year...            3.1843%            1.1690%            2.3451%            2.2328%
----------------------------------------------------------------------------------------------------------------

    The payroll adjustment is 2.2328 percent multiplied by 60 percent, 
or 1.3397 percent.
    The statute specifies that the component of the inflation 
adjustment for non-payroll costs for FY 2016 is the average annual 
percent change that occurred in the Consumer Price Index (CPI) for 
urban consumers (Washington-Baltimore, DC-MD-VA-WV; not seasonally 
adjusted; all items; annual index) for the first 3 of the preceding 4 
years of available data multiplied by 0.40, or 40 percent (see 21 
U.S.C. 379j(c)(2)(C)).
    Table 2 provides the summary data and the 3-year average percent 
change in the specified CPI for the Baltimore-Washington area. These 
data are published by the Bureau of Labor Statistics and can be found 
on their Web site at http://data.bls.gov/cgi-bin/surveymost?cu by 
checking the box marked ``Washington-Baltimore All Items, November 
1996=100--CUURA311SA0'' and then clicking on the ``Retrieve Data'' 
button.

               Table 2--Annual and 3-Year Average Percent Change in Baltimore-Washington Area CPI
----------------------------------------------------------------------------------------------------------------
             Fiscal year                     2012               2013               2014          3-Year average
----------------------------------------------------------------------------------------------------------------
Annual CPI..........................            150.212            152.500            154.847
Annual Percent Change...............            2.2024%            1.5232%            1.5390%
3-Yr Avg. Percent Change in CPI.....  .................  .................  .................            1.7549%
----------------------------------------------------------------------------------------------------------------

    The non-pay adjustment is 1.7549 percent multiplied by 40 percent, 
or 0.7019 percent.
    Next, the payroll adjustment (1.3397 percent or 0.013397) is added 
to the non-pay adjustment (0.7019 percent or 0.007019), for a total of 
2.0416 percent (or 0.020416). To complete the inflation adjustment, 1 
(100 percent or 1.0) is added for a total base inflation adjustment of 
1.020416 for FY 2016.
    MDUFA III provides for this inflation adjustment to be compounded 
for FY 2015 and each subsequent fiscal year (see 21 U.S.C. 
379j(c)(2)(B)(ii)). The base inflation adjustment for FY 2016 
(1.020416) is compounded by multiplying it by the compounded applicable 
inflation adjustment for FY 2015 (1.04316), as published in the Federal 
Register of July 30, 2014 (79 FR 44178 to 44184), to reach the 
applicable inflation adjustment of 1.064457 (rounded) (1.020416 times 
1.04316) for FY 2016. We then multiply the total revenue amount for FY 
2016 ($129,339,949) by 1.064457, yielding an inflation adjusted total 
revenue amount of $137,677,000 (rounded to the nearest thousand 
dollars).

III. Fees for FY 2016

    Under the FD&C Act, all submission fees and the periodic reporting 
fee are set as a percent of the standard (full) fee for a premarket 
application (see 21 U.S.C. 379j(a)(2)(A)). Table 3 provides the last 3 
years of fee paying submission counts and the 3-year average. These 
numbers are used to project the fee paying submission counts that FDA 
will receive in FY 2016. The fee paying submission counts are published 
in the MDUFA Financial Report to Congress each year.

                                Table 3--3-Year Average of Fee Paying Submissions
----------------------------------------------------------------------------------------------------------------
          Application type              FY 2012 actual     FY 2013 actual     FY 2014 actual     3-Year average
----------------------------------------------------------------------------------------------------------------
Full Fee Applications...............                 25                 23                 25                 24
    Small Business..................                  6                  9                  5                  7
Panel-Track Supplement..............                 12                 19                 12                 14
    Small Business..................                  0                  0                  3                  1
180-Day Supplements.................                145                128                122                132
    Small Business..................                 21                 21                 24                 22
Real-Time Supplements...............                196                182                192                190
    Small Business..................                 22                 23                 19                 21
510(k)s.............................              2,865              3,149              3,034              3,016
    Small Business..................              1,086              1,202              1,037              1,108
30-Day Notice.......................                801                956                934                897
    Small Business..................                 60                 69                 91                 73
513(g) Request for Classification                    46                 65                 69                 60
 Information........................
    Small Business..................                 30                 38                 31                 33
Annual Fee for Periodic Reporting                   478                614                514                535
 \1\................................
    Small Business \1\..............                 39                 54                 56                 50
Establishment Registration \2\......  .................             23,477             24,026             23,752
----------------------------------------------------------------------------------------------------------------
\1\ Includes collection of quarter 4 billing for FY 2014 during FY 2015.
\2\ Establishment Registration total comes from the registration system and will vary from the financial report.

    The information in Table 3 is necessary to estimate the amount of 
revenue that will be collected based on the fee amounts. Table 4 
displays both the estimated revenue using the FY 2016 base fees set in 
statute and the

[[Page 46035]]

estimated revenue after the inflation adjustment to the FY 2016 base 
fees. Using the fees set in statute and the 3-year averages of fee 
paying submissions, the collections would total $138,620,884, which is 
$943,884 higher than the statutory revenue limit. Accordingly the PMA 
and establishment fee need to be decreased so that collections come as 
close to the statutory revenue limit of $137,677,000 as possible 
without exceeding the limit. This is done by calculating the percentage 
difference between the statutory revenue limit and the estimated 
resulting 2016 revenue collections, and then lowering the fees 
proportionally by that percentage (rounded to the nearest dollar). 
After recalculating the fees, a further $1 negative adjustment is made 
to the establishment fee in order for the estimated revenue to not 
exceed the statutory limit. The fees in the second column from the 
right are those we are establishing in FY 2016, which are the standard 
fees.

                           Table 4--Fees Needed To Achieve New FY 2016 Revenue Target
----------------------------------------------------------------------------------------------------------------
                                                                             Adjusted FY 2016
                                      FY 2016 Statutory      Estimated         fees to meet     FY 2016 revenue
          Application type             fees (base fees)    resulting 2016     revenue target     from adjusted
                                                              revenue        (standard fees)          fees
----------------------------------------------------------------------------------------------------------------
Full Fee Applications...............           $263,180         $6,316,320           $261,388         $6,273,312
    Small Business..................             65,795            460,565             65,347            457,429
Panel-Track Supplement..............            197,385          2,763,390            196,041          2,744,574
    Small Business..................             49,346             49,346             49,010             49,010
180-Day Supplements.................             39,477          5,210,964             39,208          5,175,456
    Small Business..................              9,869            217,118              9,802            215,644
Real-Time Supplements...............             18,423          3,500,370             18,297          3,476,340
    Small Business..................              4,606             96,726              4,574             96,054
510(k)s.............................              5,264         15,876,224              5,228         15,764,648
    Small Business..................              2,632          2,916,256              2,614          2,896,312
30-Day Notice.......................             $4,211         $3,777,267             $4,182         $3,751,254
    Small Business..................              2,106            153,738              2,091            152,643
513(g) Request for Classification                 3,553            213,180              3,529            211,740
 Information........................
    Small Business..................              1,777             58,641              1,765             58,245
Annual Fee for Periodic Reporting...              9,211          4,927,885              9,149          4,894,715
    Small Business..................              2,303            115,150              2,287            114,350
Establishment Registration..........              3,872         91,967,744              3,845         91,326,440
                                     ---------------------------------------------------------------------------
    Total...........................  .................        138,620,884  .................        137,661,256
----------------------------------------------------------------------------------------------------------------

    The standard fee (adjusted base amount) for a premarket 
application, including a BLA, and for a premarket report and a BLA 
efficacy supplement, is $261,388 for FY 2016. The fees set by reference 
to the standard fee for a premarket application are:
     For a panel-track supplement, 75 percent of the standard 
fee;
     for a 180-day supplement, 15 percent of the standard fee;
     for a real-time supplement, 7 percent of the standard fee;
     for a 510(k) premarket notification, 2 percent of the 
standard fee;
     for a 30-day notice, 1.6 percent of the standard fee;
     for a 513(g) (21 U.S.C. 360c(g)) request for 
classification information, 1.35 percent of the standard fee; and
     for an annual fee for periodic reporting concerning a 
class III device, 3.5 percent of the standard fee.
    For all submissions other than a 510(k) premarket notification, a 
30-day notice, and a 513(g) request for classification information, the 
small business fee is 25 percent of the standard (full) fee for the 
submission. (See 21 U.S.C. 379j(d)(2)(C).) For a 510(k) premarket 
notification submission, a 30-day notice, and a 513(g) request for 
classification information, the small business fee is 50 percent of the 
standard (full) fee for the submission. (See 21 U.S.C. 379j(d)(2)(C) 
and (e)(2)(C).)
    The annual fee for establishment registration, after adjustment, is 
set at $3,845 for FY 2016. There is no small business rate for the 
annual establishment registration fee; all establishments pay the same 
fee.
    Table 5 summarizes the FY 2016 rates for all medical device fees.

                                    Table 5--Medical Device Fees for FY 2016
----------------------------------------------------------------------------------------------------------------
                                             Standard fee (as a percent of
            Application fee type                 the standard fee for a      FY 2016 Standard    FY 2016 Small
                                                 premarket application)            fee            business fee
----------------------------------------------------------------------------------------------------------------
Premarket application (a PMA submitted       Base Fee Adjusted as                    $261,388            $65,347
 under section 515(c)(1) of the FD&C Act      Specified in the Statute.
 (21 U.S.C. 360e(c)(1)), a PDP submitted
 under section 515(f) of the FD&C Act (21
 U.S.C. 360e(f)), or a BLA submitted under
 section 351 of the Public Health Service
 Act (the PHS Act) (42 U.S.C. 262)).
Premarket report (submitted under section    100..........................            261,388             65,347
 515(c)(2) of the FD&C Act).
Efficacy supplement (to an approved BLA      100..........................            261,388             65,347
 under section 351 of the PHS Act).
Panel-track supplement.....................  75...........................            196,041             49,010
180-day supplement.........................  15...........................             39,208              9,802
Real-time supplement.......................  7............................             18,297              4,574
510(k) premarket notification submission...  2............................              5,228              2,614

[[Page 46036]]

 
30-day notice..............................  1.60.........................              4,182              2,091
513(g) request for classification            1.35.........................              3,529              1,765
 information.
Annual Fee Type:
    Annual fee for periodic reporting on a   3.50.........................              9,149              2,287
     class III device.
    Annual establishment registration fee    Base Fee Adjusted as                       3,845              3,845
     (to be paid by the establishment         Specified in the Statute.
     engaged in the manufacture,
     preparation, propagation, compounding,
     or processing of a device, as defined
     by 21 U.S.C. 379i(13)).
----------------------------------------------------------------------------------------------------------------

IV. How To Qualify as a Small Business for Purposes of Medical Device 
Fees

    If your business has gross receipts or sales of no more than $100 
million for the most recent tax year, you may qualify for reduced small 
business fees. If your business has gross sales or receipts of no more 
than $30 million, you may also qualify for a waiver of the fee for your 
first premarket application (PMA, PDP, or BLA) or premarket report. You 
must include the gross receipts or sales of all of your affiliates 
along with your own gross receipts or sales when determining whether 
you meet the $100 million or $30 million threshold. If you want to pay 
the small business fee rate for a submission, or you want to receive a 
waiver of the fee for your first premarket application or premarket 
report, you should submit the materials showing you qualify as a small 
business 60 days before you send your submission to FDA. If you make a 
submission before FDA finds that you qualify as a small business, you 
must pay the standard (full) fee for that submission.
    If your business qualified as a small business for FY 2015, your 
status as a small business will expire at the close of business on 
September 30, 2015. You must requalify for FY 2016 in order to pay 
small business fees during FY 2016.

A. Domestic (U.S.) Small Business

    If you are a domestic (U.S.) business, and wish to qualify as a 
small business for FY 2016, you must submit the following to FDA:
    1. A completed FY 2016 MDUFA Small Business Qualification 
Certification (Form FDA 3602). This form is provided in FDA's guidance 
document, ``FY 2016 Medical Device User Fee Small Business 
Qualification and Certification,'' available on FDA's Web site at 
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm.
    2. A certified copy of your Federal (U.S.) Income Tax Return for 
the most recent tax year. The most recent tax year will be 2015, 
except:
    If you submit your FY 2016 MDUFA Small Business Qualification 
before April 15, 2016, and you have not yet filed your return for 2015, 
you may use tax year 2014.
    If you submit your FY 2016 MDUFA Small Business Qualification on or 
after April 15, 2016, and have not yet filed your 2015 return because 
you obtained an extension, you may submit your most recent return filed 
prior to the extension.
    3. For each of your affiliates, either:
     If the affiliate is a domestic (U.S.) business, a 
certified copy of the affiliate's Federal (U.S.) Income Tax Return for 
the most recent tax year, or
     if the affiliate is a foreign business and cannot submit a 
Federal (U.S.) Income Tax Return, a National Taxing Authority 
Certification completed by, and bearing the official seal of, the 
National Taxing Authority of the country in which the firm is 
headquartered. The National Taxing Authority is the foreign equivalent 
of the U.S. Internal Revenue Service. This certification must show the 
amount of gross receipts or sales for the most recent tax year, in both 
U.S. dollars and the local currency of the country, the exchange rate 
used in converting the local currency to U.S. dollars, and the dates of 
the gross receipts or sales collected. The applicant must also submit a 
statement signed by the head of the applicant's firm or by its chief 
financial officer that the applicant has submitted certifications for 
all of its affiliates, identifying the name of each affiliate, or that 
the applicant has no affiliates.

B. Foreign Small Business

    If you are a foreign business, and wish to qualify as a small 
business for FY 2016, you must submit the following:
    1. A completed FY 2016 MDUFA Foreign Small Business Qualification 
Certification (Form FDA 3602A). This form is provided in FDA's guidance 
document, ``FY 2016 Medical Device User Fee Small Business 
Qualification and Certification,'' available on FDA's Internet site at 
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm.
    2. A National Taxing Authority Certification, completed by, and 
bearing the official seal of, the National Taxing Authority of the 
country in which the firm is headquartered. This certification must 
show the amount of gross receipts or sales for the most recent tax 
year, in both U.S. dollars and the local currency of the country, the 
exchange rate used in converting the local currency to U.S. dollars, 
and the dates of the gross receipts or sales collected.
    3. For each of your affiliates, either:
     If the affiliate is a domestic (U.S.) business, a 
certified copy of the affiliate's Federal (U.S.) Income Tax Return for 
the most recent tax year (2015 or later), or
     if the affiliate is a foreign business and cannot submit a 
Federal (U.S.) Income Tax Return, a National Taxing Authority 
Certification completed by, and bearing the official seal of, the 
National Taxing Authority of the country in which the firm is 
headquartered. The National Taxing Authority is the foreign equivalent 
of the U.S. Internal Revenue Service. This certification must show the 
amount of gross receipts or sales for the most recent tax year, in both 
U.S. dollars and the local currency of the country, the exchange rate 
used in converting the local currency to U.S. dollars, and the dates 
for the gross receipts or sales collected. The applicant must also 
submit a statement signed by the head of the applicant's firm or by its 
chief financial officer that the applicant has submitted certifications 
for all of its affiliates, identifying the name of each affiliate, or 
that the applicant has no affiliates.

V. Procedures for Paying Application Fees

    If your application or submission is subject to a fee and your 
payment is

[[Page 46037]]

received by FDA between October 1, 2015, and September 30, 2016, you 
must pay the fee in effect for FY 2016. The later of the date that the 
application is received in the reviewing center's document room or the 
date the U.S. Treasury recognizes the payment determines whether the 
fee rates for FY 2015 or FY 2016 apply. FDA must receive the correct 
fee at the time that an application is submitted, or the application 
will not be accepted for filing or review.
    FDA requests that you follow the steps below before submitting a 
medical device application subject to a fee to ensure that FDA links 
the fee with the correct application. (Note: In no case should the 
check for the fee be submitted to FDA with the application.)

A. Secure a Payment Identification Number (PIN) and Medical Device User 
Fee Cover Sheet From FDA Before Submitting Either the Application or 
the Payment

    Log into the User Fee System at: https://userfees.fda.gov/OA_HTML/mdufmaCAcdLogin.jsp. Complete the Medical Device User Fee cover sheet. 
Be sure you choose the correct application submission date range. (Two 
choices will be offered until October 1, 2015. One choice is for 
applications and fees that will be received on or before September 30, 
2015, which are subject to FY 2015 fee rates. A second choice is for 
applications and fees received on or after October 1, 2015, which are 
subject to FY 2016 fee rates.) After completing data entry, print a 
copy of the Medical Device User Fee cover sheet and note the unique PIN 
located in the upper right-hand corner of the printed cover sheet.

B. Electronically Transmit a Copy of the Printed Cover Sheet With the 
PIN

    When you are satisfied that the data on the cover sheet are 
accurate, electronically transmit the data to FDA according to 
instructions on the screen. Applicants are required to set up a user 
account and password to assure data security in the creation and 
electronic submission of cover sheets.

C. Submit Payment for the Completed Medical Device User Fee Cover Sheet

    1. If paying with credit card or electronic check (Automated 
Clearing House (ACH) also known as eCheck):
    FDA has partnered with the U.S. Department of the Treasury to 
utilize Pay.gov, a Web-based payment system, for online electronic 
payment. You may make a payment via electronic check or credit card 
after submitting your cover sheet. To pay online, select the ``Pay 
Now'' button. Credit card transactions for cover sheets cannot exceed 
$49,999.99.
    2. If paying with a paper check:
     All paper checks must be in U.S. currency from a U.S. bank 
and made payable to the Food and Drug Administration. (If needed, FDA's 
tax identification number is 53-0196965.)
     Please write your application's unique PIN (from the upper 
right-hand corner of your completed Medical Device User Fee cover 
sheet) on your check.
     Mail the paper check and a copy of the completed cover 
sheet to: Food and Drug Administration, P.O. Box 979033, St. Louis, MO 
63197-9000. (Please note that this address is for payments of 
application and annual report fees only and is not to be used for 
payment of annual establishment registration fees.)
    If you prefer to send a check by a courier, the courier may deliver 
the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005 
Convention Plaza, St. Louis, MO 63101. (Note: This address is for 
courier delivery only. Contact U.S. Bank at 314-418-4013 if you have 
any questions about courier delivery.)
    3. If paying with a wire transfer:
     Please include your application's unique PIN (from the 
upper right-hand corner of your completed Medical Device User Fee cover 
sheet) in your wire transfer. Without the PIN, your payment may not be 
applied to your cover sheet and review of your application may be 
delayed.
     The originating financial institution may charge a wire 
transfer fee. Ask your financial institution about the fee and add it 
to your payment to ensure that your cover sheet is fully paid.
    Use the following account information when sending a wire transfer: 
New York Federal Reserve Bank, U.S. Department of Treasury, TREAS NYC, 
33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 
021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., 
Silver Spring, MD 20993-0002.
    FDA records the official application receipt date as the later of 
the following: (1) The date the application was received by FDA or (2) 
the date the U.S. Treasury recognizes the payment. It is helpful if the 
fee arrives at the bank at least 1 day before the application arrives 
at FDA.

D. Submit Your Application to FDA With a Copy of the Completed Medical 
Device User Fee Cover Sheet

    Please submit your application and a copy of the completed Medical 
Device User Fee cover sheet to one of the following addresses:
    1. Medical device applications should be submitted to: Food and 
Drug Administration, Center for Devices and Radiological Health, 
Document Mail Center, 10903 New Hampshire Ave., Building 66, Rm. 0609, 
Silver Spring, MD 20993-0002.
    2. Biologics license applications should be sent to: Food and Drug 
Administration, Center for Biologics Evaluation and Research, Document 
Control Center, 10903 New Hampshire Ave, Building 71, Rm. G112, Silver 
Spring, MD 20993-0002.

VI. Procedures for Paying the Annual Fee for Periodic Reporting

    You will be invoiced at the end of the quarter in which your PMA 
Periodic Report is due. Invoices will be sent based on the details 
included on your PMA file. You are responsible for ensuring FDA has 
your current billing information, and you may update your contact 
information for the PMA by submitting an amendment.
    1. The preferred payment method is online using electronic check 
(Automated Clearing House (ACH) also known as eCheck) or credit card 
(Discover, VISA, MasterCard, American Express). Secure electronic 
payments can be submitted using the User Fees Payment Portal at https://userfees.fda.gov/pay. After searching for and locating your invoice, 
click ``Pay Now'' to be redirected to Pay.gov. Note that electronic 
payment options are based on the balance due. Payment by credit card is 
available for balances that do not exceed $49,999.99. If the balance 
exceeds this amount, only the ACH option is available. Payments must be 
drawn on U.S bank accounts or made with U.S. credit cards.
    2. If paying with a paper check:
    All paper checks must be in U.S. currency from a U.S. bank and made 
payable to the Food and Drug Administration. (If needed, FDA's tax 
identification number is 53-0196965.)
     Please write your invoice number on the check.
     Mail the paper check and a copy of invoice to: Food and 
Drug Administration, P.O. Box 979033, St. Louis, MO 63197-9000.

    (Please note that this address is for payments of application 
and annual report fees only and is not to be used for payment of 
annual establishment registration fees.)

    If you prefer to send a check by a courier, the courier may deliver 
the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005 
Convention Plaza, St. Louis, MO 63101.


[[Page 46038]]


    (Note: This address is for courier delivery only. Contact the 
U.S. Bank at 314-418-4013 if you have any questions about courier 
delivery.)

    3. If paying with a wire transfer:
     Please include your invoice number in your wire transfer. 
Without the invoice number, your payment may not be applied and you may 
be referred to collections.
     The originating financial institution may charge a wire 
transfer fee. Ask your financial institution about the fee and add it 
to your payment to ensure that your invoice is fully paid.
    Use the following account information when sending a wire transfer: 
New York Federal Reserve Bank, U.S. Department of the Treasury, TREAS 
NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing 
No. 021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., 
Silver Spring, MD 20993-0002.

VII. Procedures for Paying Annual Establishment Fees

    To pay the annual establishment fee, firms must access the Device 
Facility User Fee (DFUF) Web site at https://userfees.fda.gov/OA_HTML/furls.jsp. (FDA has verified the Web site address, but FDA is not 
responsible for any subsequent changes to the Web site address after 
this document publishes in the Federal Register.) Create a DFUF order 
and you will be issued a PIN when you place your order. After payment 
has been processed, you will be issued a payment confirmation number 
(PCN). You will not be able to register your establishment if you do 
not have a PIN and a PCN. An establishment required to pay an annual 
establishment registration fee is not legally registered in FY 2016 
until it has completed the steps below to register and pay any 
applicable fee. (See 21 U.S.C. 379j(g)(2).)
    Companies that do not manufacture any product other than a licensed 
biologic are required to register in the Blood Establishment 
Registration (BER) system. FDA's Center for Biologics Evaluation and 
Research (CBER) will send establishment registration fee invoices 
annually to these companies.

A. Submit a DFUF Order With a PIN From FDA Before Registering or 
Submitting Payment

    To submit a DFUF Order, you must create or have previously created 
a user account and password for the user fee Web site listed previously 
in this section. After creating a user name and password, log into the 
Establishment Registration User Fee FY 2016 store. Complete the DFUF 
order by entering the number of establishments you are registering that 
require payment. When you are satisfied that the information in the 
order is accurate, electronically transmit the data to FDA according to 
instructions on the screen. Print a copy of the final DFUF order and 
note the unique PIN located in the upper right-hand corner of the 
printed order.

B. Pay For Your DFUF Order

    Unless paying by credit card, all payments must be in U.S. currency 
and drawn on a U.S. bank.
    1. If paying by credit card or electronic check (ACH or eCheck):
    The DFUF order will include payment information, including details 
on how you can pay online using a credit card or electronic check. 
Follow the instructions provided to make an electronic payment.
    2. If paying with a paper check:
    You may pay by a check, in U.S. dollars and drawn on a U.S. bank, 
mailed to: Food and Drug Administration, P.O. Box 979108, St. Louis, MO 
63197-9000. (Note: This address is different from the address for 
payments of application and annual report fees and is to be used only 
for payment of annual establishment registration fees.)
    If a check is sent by a courier that requests a street address, the 
courier can deliver the check to: U.S. Bank, Attn: Government Lockbox 
979108, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This U.S. 
Bank address is for courier delivery only; do not send mail to this 
address.)
    Please make sure that both of the following are written on your 
check: (1) The FDA post office box number (P.O. Box 979108) and (2) the 
PIN that is printed on your order. Include a copy of your printed order 
when you mail your check.
    3. If paying with a wire transfer:
    Wire transfers may also be used to pay annual establishment fees. 
To send a wire transfer, please read and comply with the following 
information:
    Include your order's unique PIN (in the upper right-hand corner of 
your completed DFUF order) in your wire transfer. Without the PIN, your 
payment may not be applied to your facility and your registration may 
be delayed.
    The originating financial institution may charge a wire transfer 
fee. Ask your financial institution about the fee and add it to your 
payment to ensure that your order is fully paid. Use the following 
account information when sending a wire transfer: New York Federal 
Reserve Bank, U.S. Dept. of Treasury, TREAS NYC, 33 Liberty St., New 
York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT: 
FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., Silver Spring, MD 
20993-0002. (If needed, FDA's tax identification number is 53-0196965.)

C. Complete the Information Online To Update Your Establishment's 
Annual Registration for FY 2016, or To Register a New Establishment for 
FY 2016

    Go to the Center for Devices and Radiological Health's Web site at 
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/RegistrationandListing/default.htm and click the 
``Access Electronic Registration'' link on the left side of the page. 
This opens up a new page with important information about the FDA 
Unified Registration and Listing System (FURLS). After reading this 
information, click on the ``Access Electronic Registration'' link in 
the middle of the page. This link takes you to an FDA Industry Systems 
page with tutorials that demonstrate how to create a new FURLS user 
account if your establishment did not create an account in FY 2015. 
Manufacturers of licensed biologics should register in the BER system 
at http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/EstablishmentRegistration/BloodEstablishmentRegistration/default.htm.
    Enter your existing account ID and password to log into FURLS. From 
the FURLS/FDA Industry Systems menu, click on the Device Registration 
and Listing Module (DRLM) of FURLS button. New establishments will need 
to register and existing establishments will update their annual 
registration using choices on the DRLM menu. When you choose to 
register or update your annual registration, the system will prompt you 
through the entry of information about your establishment and your 
devices. If you have any problems with this process, email: 
reglist@cdrh.fda.gov or call 301-796-7400 for assistance. (Note: This 
email address and telephone number are for assistance with 
establishment registration only; they are not to be used for questions 
related to other aspects of medical device user fees.) Problems with 
BERS should be directed to http://www.accessdata.fda.gov/scripts/email/cber/bldregcontact.cfm or call 240-402-8360.

D. Enter Your DFUF Order PIN and PCN

    After completing your annual or initial registration and device 
listing, you will be prompted to enter your DFUF order PIN and PCN, 
when applicable. This process does not apply to establishments engaged 
only in the

[[Page 46039]]

manufacture, preparation, propagation, compounding, or processing of 
licensed biologic devices. CBER will send invoices for payment of the 
establishment registration fee to such establishments.

    Dated: July 28, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-18907 Filed 7-31-15; 8:45 am]
BILLING CODE 4164-01-P